Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-05-07

An epidemiological research on sunbed use and melanoma and on risk factors of melanoma arising on the head and neck or in body sites not exposed to the sunlight

Obiettivo

Objectives:

* To assess the impact of exposure to sunbeds on melanoma risk.
* To study risk determinants of melanoma arising in body areas normally not exposed to sunlight (MUS) and of non-lentigo melanoma of the head and neck (HNM).

BACKGROUND: An increased risk of melanoma seems associated with sunbed use, but we are still unable to quantify the amount of risk associated with that fashion. Surveys indicate that in 1995, between 15 and 50% of Northern European subjects were using sunbeds. Defining norms for sunbed commercialisation and use remains a difficult exercise due to the absence of sufficient data on actual impact of sunbed exposure in humans. Risk determinants of melanoma arising in body areas normally not exposed to sunlight (MUS) and of non-lentigo melanoma of the head and neck (HNM) are not well understood.

OBJECTIVE:
1) To assess the impact of exposure to sunbeds on melanomarisk;
2)To study risk determinants of MUS and HNM.

METHODS: multicenter case-control study including at least 600 melanoma cases aged 15 to 39 years old and 600 controls chosen at random in the same municipality. Young subjects are best suited for exploring the sunbed issue: rising melanoma incidence is more marked among them, they display the highest exposure rate to sunbeds, they are less prone to recall bias, and have the most hazardous behaviours towards the sunlight. 360 Subjects of all age presenting with MUS or HNM with 360 controls will also be included. MUS and HNM being partof the young melanoma sample will indeed be part of the later sample.

SIDE STUDIES: In order to increase our understanding of biological mechanisms active in melanoma, two side studies are planned. Side Study I: production of pheomelanin could be a strong genetically determined risk factor for melanoma. Pheo- to eumelanins ratio will be compared in subsamples of cases and controls.

Side Study II: Presence of p53 VUB signature mutations will be assessed in adjacent normal skin on selected young male cases of MUS and of trunk melanoma. Comparison of overall functional capacity of p53 will be compared between 20 selected young melanoma patients and 20 healthy controls. To maximize our comprehension of gene-environment interactions, Side Studies I and II will examine the same sample of melanoma cases.

PUBLIC HEALTH RELEVANCE: This research represents an opportunity for producing high quality data upon which to devise public health and economic policies about sunbed use. Side studies will enable to better define high risk subjects, and thus target prevention efforts intended to stop the rising melanoma incidence in our countries, mainly among young adults.

Keywords: Melanoma, Sunbed, Epidemiology, Molecular epidemiology, Genetic marker, prevention, public heath policy. 02 02

Campo scientifico (EuroSciVoc)

CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: Il Vocabolario Scientifico Europeo.

È necessario effettuare l’accesso o registrarsi per utilizzare questa funzione

Programma(i)

Programmi di finanziamento pluriennali che definiscono le priorità dell’UE in materia di ricerca e innovazione.

Argomento(i)

Gli inviti a presentare proposte sono suddivisi per argomenti. Un argomento definisce un’area o un tema specifico per il quale i candidati possono presentare proposte. La descrizione di un argomento comprende il suo ambito specifico e l’impatto previsto del progetto finanziato.

Invito a presentare proposte

Procedura per invitare i candidati a presentare proposte di progetti, con l’obiettivo di ricevere finanziamenti dall’UE.

Dati non disponibili

Meccanismo di finanziamento

Meccanismo di finanziamento (o «Tipo di azione») all’interno di un programma con caratteristiche comuni. Specifica: l’ambito di ciò che viene finanziato; il tasso di rimborso; i criteri di valutazione specifici per qualificarsi per il finanziamento; l’uso di forme semplificate di costi come gli importi forfettari.

CSC - Cost-sharing contracts

Coordinatore

Istituto Europeo di Oncologia Srl
Contributo UE
Nessun dato
Indirizzo
Via Ripamonti
20141 Milano
Italia

Mostra sulla mappa

Costo totale

I costi totali sostenuti dall’organizzazione per partecipare al progetto, compresi i costi diretti e indiretti. Questo importo è un sottoinsieme del bilancio complessivo del progetto.

Nessun dato

Partecipanti (7)

Il mio fascicolo 0 0